Pain Therapeutics Gets Investors' Painkiller Suit Nixed
A Texas federal judge on Wednesday dismissed a class action alleging Pain Therapeutics Inc.'s brass misled investors into thinking the biopharmaceutical company's newly developed painkiller would receive U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article